TRIAMCINOLONE ACETONIDE 1 mg/g Cream, 80 g
by Direct Rx · 80 g in 1 TUBE (72189-330-80)
NDC 72189-0330-80
🏷️ FDA NDC (as labeled)
72189-330-80
billing pads the product segment with a zero
Rx only
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Past resolved recalls for this product (1)
Class II · Sep 12, 2022 · Completed — CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness. (Direct Rx) · FDA recall D-1535-2022
🆔 Identity & classification
FDA NDC (as labeled)
72189-330-80
Product NDC
72189-330
11-digit billing NDC
72189033080
NCPDP billing unit
GM — per gram (weight)
RxCUI
1014314
UNII
F446C597KA
Application #
ANDA086413
SPL Set ID
d92e9eaf-3a79-76d7-e053-2995a90ae28d
Established class (EPC)
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2022-03-01
Route
TOPICAL
Dosage form
CREAM
Substance
TRIAMCINOLONE ACETONIDE
GPI-14
90550085103710
GPI class
Triamcinolone Acetonide
GCN Seq No
007594
GCN
31232
HICL code
002891
Ingredient (HICL)
Triamcinolone Acetonide
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q5
Therapeutic class — intermediate (HIC2)
Agents Acting Principally On The Skin
HIC3 code
Q5P
Therapeutic class — specific (HIC3)
Topical Anti-Inflammatory Steroidal
AHFS code
48:10.08.00
AHFS class
Corticosteroids (Respiratory Tract)
FDB label name
TRIAMCINOLONE 0.1% CREAM
FDB brand name
Triamcinolone Acetonide
Legend status
F — Federal legend — prescription drug or device
TE code (Orange Book)
AT · RLD · RS
Why two NDCs?
The FDA registers this code as 72189-330-80 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72189-0330-80. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Corticosteroid class.
Pharmacologic class
Corticosteroid
Drug family (ATC)
Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works
Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerDirect Rx
Application holderPADAGIS US LLC
FDA applicationANDA086413 (ANDA)
Labeler code72189
First marketedMar 2022
Product typeHuman Prescription Drug
Portfolio204 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name TRIAMCINOLONE 0.1% CREAM Ingredient Triamcinolone Acetonide
📗 Our plain-language guide HelloPharmacist
- Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
- I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
- That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
- I have diabetes. Should I be worried about using triamcinolone?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about triamcinolone acetonide cream?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.1230 | $9.84 / 80 g |
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Triamcinolone Acetonide 1 mg/g 45802-0064-05 | Padagis | 454 g | $0.027 | AT | Availability likely | — |
| triamcinolone acetonide 1 mg/g 00168-0004-15 | E. | 1 tube | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 00713-0225-15 | Cosette | 1 tube | $0.102 | AT | Discontinued | — |
| Triamcinolone Acetonide 1 mg/g 16714-0986-01 | NorthStar | 1 tube | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 21922-0062-04 | Encube | 1 tube | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 33342-0329-15 | Macleods | 1 tube | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 51672-1282-01 | Sun | 1 tube | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 67877-0251-15 | Ascend | 15 g | $0.102 | AT | Availability likely | — |
| Triamcinolone Acetonide 1 mg/g 71656-0042-15 | Saptalis | 1 tube | $0.102 | AT | Availability likely | — |
| Triderm 1 mg/g 00316-0170-01 | Crown | 1 tube | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 50090-0162-00 | A-S | 80 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 50090-0228-00 | A-S | 15 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 50090-2106-00 | A-S | 30000 mg | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 50090-6547-00 | A-S | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 50090-6566-00 | A-S | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 52817-0811-15 | TruPharma, | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 61919-0234-30 | Direct_Rx | 30 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 61919-0650-15 | DIRECTRX | 15 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 63187-0025-15 | Proficient | 15 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 63187-0053-15 | Proficient | 15 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 63187-0870-15 | Proficient | 1 tube | — | — | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 63629-8778-01 | Bryant | 15 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 63629-8779-01 | Bryant | 30 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 63629-8780-01 | Bryant | 80 g | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 63629-8781-01 | Bryant | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 63629-9573-01 | Bryant | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 63629-9574-01 | Bryant | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 66267-0933-80 | NuCare | 80 g | — | — | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-2736-03 | NuCare | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-3666-03 | NuCare | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-3852-08 | NuCare | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-3982-05 | NuCare | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-4383-05 | NuCare | 15 g | — | — | FDA listed | — |
| triamcinolone acetonide 1 mg/g 68071-4391-03 | NuCare | 30 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68071-4945-05 | NuCare | 15 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68462-0131-17 | Glenmark | 1 tube | — | — | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68788-7797-01 | Preferred | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68788-8350-01 | Preferred | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68788-8356-00 | Preferred | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 68788-8753-01 | Preferred | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 70518-1524-00 | REMEDYREPACK | 15 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 70518-2285-00 | REMEDYREPACK | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 70518-2403-00 | REMEDYREPACK | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 70518-2963-00 | REMEDYREPACK | 1 tube | — | AT | Discontinued | — |
| Triamcinolone Acetonide 1 mg/g 70518-4527-00 | REMEDYREPACK | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 71205-0627-15 | Proficient | 1 tube | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 71335-2211-01 | Bryant | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 71335-2712-01 | Bryant | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 71335-2713-01 | Bryant | 80 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 72162-1386-04 | Bryant | 1 tube | — | AT | FDA listed | — |
| Triamcinolone acetonide 1 mg/g 72162-1832-03 | Bryant | 30 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 72189-0039-80 | Direct_Rx | 80 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 72189-0277-15 | Direct_Rx | 15 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/gthis 72189-0330-80 | Direct | 80 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 72189-0571-80 | Direct_rx | 80 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 72189-0670-30 | Direct_rx | 30 g | — | AT | FDA listed | — |
| Dermavyx 72835-0777-02 | V2 | 1 kit | — | — | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 76420-0203-15 | Asclemed | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 76420-0348-00 | Asclemed | 454 g | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 82804-0071-30 | Proficient | 1 tube | — | AT | FDA listed | — |
| Triamcinolone Acetonide 1 mg/g 82804-0145-30 | Proficient | 1 tube | — | AT | FDA listed | — |
| Triadermex 84460-0100-08 | Florrax | 1 kit | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2022
On the market since
Mar 2022
📍
2026
Currently FDA-listed
4 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Triamcinolone Acetonide (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 34%
Female · 66%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 72189-0330-80 You're viewing this | 80 g in 1 TUBE (72189-330-80) | 2022-03-01 | Active |
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 72189-330-80, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 72189-0330-80, written without dashes as 72189033080. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 72189-0330-80, the first segment (72189) is the labeler code FDA assigned to Direct Rx; the middle segment (0330) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (80) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Direct Rx. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Direct Rx is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⛔ Contraindications
🤒 Adverse Reactions
🧬 Clinical Pharmacology
📦 How Supplied / Storage and Handling
📋 Description
🎯 Indications and Usage ▾
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
⏱️ Dosage and Administration ▾
Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressing should be discontinued and appropriate antimicrobial therapy instituted.
⛔ Contraindications ▾
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
🤒 Adverse Reactions ▾
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.
🧬 Clinical Pharmacology ▾
Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids.
There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. Pharmacokinetics - The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin.
Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses (see DOSAGE AND ADMINISTRATION).
Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Some of the topical corticosteroids and their metabolites are also excreted into the bile.
📦 How Supplied / Storage and Handling ▾
Triamcinolone Acetonide Cream USP, 0.025% is available as follows: 15 g tube (NDC 45802-063-35) 80 g tube (NDC 45802-063-36) 454 g jar (NDC 45802-063-05) Triamcinolone Acetonide Cream USP, 0.1% is available as follows: 15 g tube (NDC 45802-064-35) 80 g tube (NDC 45802-064-36) 454 g jar (NDC 45802-064-05) Triamcinolone Acetonide Cream USP, 0.5% is available as follows: 15 g tube (NDC 45802-065-35)
📋 Description ▾
The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and anti-pruritic agents. Triamcinolone acetonide is designated chemically as pregna-1,4-diene-3,20-dione,9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene) bis (oxy)]-,(11ß,16α)-. C24H31FO6, and M.W. of 434.51; CAS Reg.
No. 76-25-5. [Structural Formula] Each gram of 0.025%, 0.1% and 0.5% Triamcinolone Acetonide Cream USP contains 0.25 mg, 1 mg, or 5 mg triamcinolone acetonide respectively, in a washable cream base of cetyl alcohol, cetyl esters wax, glycerin, glyceryl monostearate, isopropyl palmitate, polysorbate-60, propylene glycol, purified water, sorbic acid, and sorbitan monostearate.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.